slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 7,321-7,350
Pages 395
Rows per page 30
Slide function
7,321-7,350 of 11,828
24
The chart tracks leverage from PF YE 2022 through Q4 2023E, with a target range for the future.Crocs | Investor Presentation Deck | 29 slides · Crocs
Pitch deck Investor relations 1 hit
06
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Logic Chain1 hit
07
Enochian Biosciences | Investor Presentation Deck | 28 slidesEnochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
The slide presents two bar charts (weight and volume) and a grid of tumor photographs as visual proof of concept.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
17
Includes visual evidence of tumor size alongside quantitative bar charts with statistical significance markers.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
18
The table shows 0/3 incidence of metastasis/ascites in the RENB-DC11 group compared to high incidence in control groups.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
20
N=2-3 sample size indicated at bottom left.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
21
The slide demonstrates efficacy of RENB-DC11 in stimulating immune response (IFNg production) in a tumor model.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
22
The slide uses immunohistochemistry (brown staining) to visualize CD4+ T-cells, quantified in the bar chart.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
23
The slide uses immunohistochemistry images and a corresponding bar chart to demonstrate efficacy.Enochian Biosciences | Investor Presentation Deck | 28 slides · Renovaro Biosciences
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
11
The slide combines a biological pathway diagram with a clinical trial summary table to demonstrate clinical validation.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
15
Waterfall plots showing best percentage change from baseline for two distinct patient cohorts.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
19
The chart is a mirrored bar chart (diverging bar chart) showing AE frequency by grade.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · EvidenceLoop · Quick Win Big Bet1 hit
25
Shows efficacy data for ERAS-007 in combination with Encorafenib and Cetuximab.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
26
Includes waterfall plot and swimmer plot for clinical trial results.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Solution1 hit
32
The chart is a Kaplan-Meier survival plot comparing three treatment groups.Erasca | Investor Presentation Deck | 41 slides · Erasca
Pitch deck Investor relations Beat · Market Sizing1 hit
04
The slide highlights organizational growth in compliance-related roles.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations 1 hit
06
The chart uses a trend line to emphasize the reduction in concentration.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations Loop · Logic Chain1 hit
15
The slide uses a consistent 3-period comparison (4Q22, 3Q23, 4Q23) across four key financial metrics.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
16
The slide uses bar charts to demonstrate financial trends over three specific quarters.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
21
The slide highlights financial performance metrics.FinWise Bancorp | Investor Presentation Deck | 24 slides · FinWise Bancorp
Pitch deck Investor relations Beat · FinancialsLoop · Cost Of Inaction1 hit
06
First Foundation | Investor Presentation Deck | 45 slidesFirst Foundation | Investor Presentation Deck | 45 slides · First Foundation
Pitch deck Investor relations 1 hit
16
The slide shows a clear pivot from diversified lending (2019-2022) to a heavy concentration in commercial business by 4Q23.First Foundation | Investor Presentation Deck | 45 slides · First Foundation
Pitch deck Investor relations 1 hit
18
The slide uses a side-by-side table format to contrast two distinct loan asset classes.First Foundation | Investor Presentation Deck | 45 slides · First Foundation
Pitch deck Investor relations 1 hit
24
The slide uses a combination of bulleted lists for qualitative data and charts for quantitative growth and demographic segmentation.First Foundation | Investor Presentation Deck | 45 slides · First Foundation
Pitch deck Investor relations 1 hit
27
Includes a hub-and-spoke diagram illustrating client acquisition channels.First Foundation | Investor Presentation Deck | 45 slides · First Foundation
Pitch deck Investor relations 1 hit
32
The slide uses a dashed vertical line to separate annual data from quarterly data points.First Foundation | Investor Presentation Deck | 45 slides · First Foundation
Pitch deck Investor relations 1 hit
12
The slide uses a timeline to establish a history of innovation, followed by a categorical display of current product features.Flutter | Securities Offering Presentation Deck | 30 slides · Flutter Entertainment
Pitch deck Investor relations Beat · Product1 hit
25
The slide uses a funnel-like structure to show how operational pillars lead to specific metrics and ultimately to long-term value creation.Flutter | Securities Offering Presentation Deck | 30 slides · Flutter Entertainment
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
04
Uses an analogy to establish market positioning.Freightos | Investor Presentation Deck | 35 slides · Freightos
Pitch deck Investor relations 1 hit